Related Experiment Video
Updated: Jun 8, 2026
09:09
Lethality Bioassay Using Artemia salina L.
Published on: October 11, 2022
[Low mortality following salicylic poisoning]
Julie Derving Karsbøl1, Henrik L Jørgensen, Kim Dalhoff
1Klinisk Farmakologisk Afdeling, Bispebjerg Hospital, 2400 København NV, Denmark.
Ugeskrift for Laeger
|September 15, 2010
Summary
Salicylic poisoning outcomes are generally favorable, but chronic cases, older age, and existing medical conditions increase complication risks. Neurological symptoms indicate a poor prognosis in salicylic acid poisoning.
Area of Science:
- Toxicology
- Clinical Medicine
- Prognostic Factor Analysis
Context:
- Salicylic poisoning poses a significant clinical challenge.
- Identifying prognostic factors is crucial for patient management.
- Previous research has not fully elucidated risk factors for complicated outcomes.
Purpose:
- To identify prognostic factors for complicated outcomes in patients with salicylic poisoning.
- To analyze clinical and biochemical data in relation to poisoning severity and outcome.
- To determine risk factors associated with adverse events in salicylic acid overdose.
Summary:
- A retrospective chart review of 53 patients with salicylic poisoning (serum salicylate ≥ 2 mmol/l) was conducted.
- Complicated outcomes (prolonged hospitalization, dialysis, death) were associated with chronic poisoning, pre-existing medical diseases, older age, and alcoholism.
- Neurological symptoms (somnolence, confusion) and low serum bicarbonate were independent predictors of complicated outcomes, with an odds ratio of 6.6 for neurological symptoms.
Impact:
- This study highlights key indicators for predicting poor prognosis in salicylic poisoning.
- Findings can aid clinicians in risk stratification and timely intervention for high-risk patients.
- Understanding these factors can improve patient outcomes and resource allocation in managing salicylate toxicity.
More Related Videos
Related Concept Videos
01:26Pharmaceutical Poisoning: Treatment Strategies
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
01:14Prevention of Further Absorption of Poison
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
01:26Enhanced Elimination of Poison
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
01:26Anticholinesterase Agents: Poisoning and Treatment
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...